Policy & Regulation
Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology
15 April 2026 - Biotechnology company Circio Holding ASA (OSE:CRNA) announced on Wednesday that it has entered into an evaluation agreement with Canadian biotechnology company Acuitas Therapeutics to ...
GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma
15 April 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) reported on Wednesday that it has completed the acquisition of 35Pharma Inc, a Canada-based clinical-stage biopharmaceutical co...
Poolbeg Pharma secures MHRA approval for POLB 001 trial as US research highlights multi-billion dollar potential
15 April 2026 - Biopharmaceutical company Poolbeg Pharma plc (AIM: POLB) announced on Wednesday that it has received Clinical Trial Authorisation from the UK Medicines and Healthcare products Regulato...
Asgard Therapeutics appoints chief medical officer
15 April 2026 - Asgard Therapeutics, a Swedish biotech company focused on in vivo direct cell reprogramming for cancer immunotherapy, announced on Tuesday the appointment of Prof Dr Wolfram Brugger as...
Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting
15 April 2026 - Mestag Therapeutics, a UK-based biotech company using fibroblast immunology to develop treatments for patients with cancer and inflammatory disease, announced on Tuesday that it has be...
CrossBridge Bio to be acquired by Eli Lilly
14 April 2026 - CrossBridge Bio Inc, a pre-clinical biotechnology company developing next-generation dual-payload antibody-drug conjugates (ADCs), announced on Tuesday that it has entered into a defin...